跳至主要内容
临床试验/IRCT201106026691N1
IRCT201106026691N1已完成3 期

Effect of Buspirone added to Typical Antipsychotics on Positive and Negative symptoms in schizophrenia (a double blind, placebo controlled, randomized trial)

Mazandaran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18-65; Diagnosis of Schizophrenia based on DSMIV-TR; Chronic Schizophrenia(over 2 years); Ongoing treatment with Typical Antipsychotics.
  • Exclusion criteria:Allergic to Buspirone; Any chronic medical problem; Substance dependency; Any other Psychiatric Disorder in Axis I or II; Pregnancy or Breast feeding.

排除标准

  • 未提供

研究者

相似试验